Blog

What is a normal BMI for men? Learn how BMI relates to age, muscle mass, belly fat, waist circumference, metabolic health, GLP-1 medications, and bariatric surgery.

Thinking about buying GLP-3 peptide (Retatrutide) online without a prescription? Read this educational patient story about disappointing Retatrutide results, dosing confusion, constipation, dizziness, and how switching to physician-supervised prescription medical weight loss with personalized follow-up and dose adjustments changed everything.

Thinking about starting Tesamorelin therapy? Learn about common Tesamorelin regrets, realistic expectations, side effects, daily injections, costs, and what physicians want patients to know before beginning treatment. Discover how proper medical supervision can help you make an informed decision and...

Wondering if you should take a break from Tesamorelin? This physician-reviewed guide explains whether cycling is necessary, what happens when you pause treatment, how to restart safely, and what current research says about long-term Tesamorelin therapy. Includes expert answers, related...

Learn whether you can stop Tesamorelin suddenly or if tapering is recommended. Physician-reviewed guide covering what happens after stopping, restarting Tesamorelin, belly fat changes, treatment duration, and common patient questions.

Learn how healthcare providers determine Tesamorelin dosage for belly fat, what affects treatment plans, and why there is no one-size-fits-all approach. Explore physician-guided care, body composition, visceral fat, and use our Tesamorelin dosage calculator to estimate dose, units, mL, and...

The Medicare GLP-1 Bridge Program launches July 1, 2026, giving eligible Medicare beneficiaries access to covered weight loss medications including Wegovy®, Foundayo®, and Zepbound® KwikPen®. Patients who qualify may receive treatment with a fixed $50 copay after provider review and...

Explore potential BPC-157 side effects in men and women, including common reactions, safety considerations, kidney and liver concerns, and what current research says about this popular recovery peptide.